QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
NASDAQ:OPK

OPKO Health Stock Forecast, Price & News

$4.02
+0.12 (+3.08%)
(As of 12/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.85
$4.06
50-Day Range
$3.52
$4.44
52-Week Range
$3.26
$6.27
Volume
3.86 million shs
Average Volume
4.89 million shs
Market Capitalization
$2.74 billion
P/E Ratio
36.55
Dividend Yield
N/A
Beta
1.67
30 days | 90 days | 365 days | Advanced Chart
Receive OPK News and Ratings via Email

Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter.


OPKO Health logo

About OPKO Health

OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:OPK
CUSIP
68375N10
Employees
5,269
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.44 billion
Cash Flow
$0.18 per share
Book Value
$2.59 per share

Profitability

Net Income
$30.59 million
Pretax Margin
5.23%

Debt

Price-To-Earnings

Miscellaneous

Free Float
398,789,000
Market Cap
$2.74 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/28/2021
Today
12/08/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/17/2022

MarketRank

Overall MarketRank

2.27 out of 5 stars

Medical Sector

316th out of 1,394 stocks

Pharmaceutical Preparations Industry

140th out of 674 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












OPKO Health (NASDAQ:OPK) Frequently Asked Questions

Is OPKO Health a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OPKO Health stock.
View analyst ratings for OPKO Health
or view top-rated stocks.

How has OPKO Health's stock price been impacted by Coronavirus (COVID-19)?

OPKO Health's stock was trading at $1.69 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OPK shares have increased by 137.9% and is now trading at $4.02.
View which stocks have been most impacted by COVID-19
.

When is OPKO Health's next earnings date?

OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for OPKO Health
.

How were OPKO Health's earnings last quarter?

OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings results on Thursday, October, 28th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.05. The biotechnology company had revenue of $385.80 million for the quarter, compared to analysts' expectations of $302.27 million. OPKO Health had a net margin of 4.06% and a trailing twelve-month return on equity of 4.42%. OPKO Health's revenue was down 9.9% on a year-over-year basis. During the same quarter last year, the company posted $0.04 EPS.
View OPKO Health's earnings history
.

What price target have analysts set for OPK?

3 Wall Street analysts have issued 1-year price objectives for OPKO Health's stock. Their forecasts range from $5.00 to $7.00. On average, they anticipate OPKO Health's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 49.3% from the stock's current price.
View analysts' price targets for OPKO Health
or view top-rated stocks among Wall Street analysts.

Who are OPKO Health's key executives?

OPKO Health's management team includes the following people:
  • Phillip Frost, Chairman & Chief Executive Officer
  • Jon Roger Cohen, Director & Senior Vice President
  • Adam E. Logal, CFO, Treasurer, Chief Accounting Officer & SVP
  • Jane H. Hsaio, Vice Chairman & Chief Technical Officer
  • Steven D. Rubin, Director & Executive Vice President-Administration

What is Philip Frost's approval rating as OPKO Health's CEO?

21 employees have rated OPKO Health CEO Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among OPKO Health's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OPKO Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T).

What is OPKO Health's stock symbol?

OPKO Health trades on the NASDAQ under the ticker symbol "OPK."

Who are OPKO Health's major shareholders?

OPKO Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.11%), Geode Capital Management LLC (1.13%), Dimensional Fund Advisors LP (0.66%), Nordea Investment Management AB (0.39%), Invesco Ltd. (0.39%) and Bank of New York Mellon Corp (0.29%). Company insiders that own OPKO Health stock include Anthony J Japour, Jon R Cohen, Phillip Md Et Al Frost, Robert J Shovlin and Steven D Rubin.
View institutional ownership trends for OPKO Health
.

Which institutional investors are selling OPKO Health stock?

OPK stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, BlackRock Inc., Citigroup Inc., Renaissance Technologies LLC, Morgan Stanley, Two Sigma Advisers LP, Hennion & Walsh Asset Management Inc., and New York State Common Retirement Fund.
View insider buying and selling activity for OPKO Health
or view top insider-selling stocks.

Which institutional investors are buying OPKO Health stock?

OPK stock was bought by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Wolverine Asset Management LLC, Jupiter Asset Management Ltd., Jump Financial LLC, Alliancebernstein L.P., SG Americas Securities LLC, Connor Clark & Lunn Investment Management Ltd., and Rafferty Asset Management LLC. Company insiders that have bought OPKO Health stock in the last two years include Anthony J Japour, Jon R Cohen, Phillip Md Et Al Frost, and Steven D Rubin.
View insider buying and selling activity for OPKO Health
or or view top insider-buying stocks.

How do I buy shares of OPKO Health?

Shares of OPK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OPKO Health's stock price today?

One share of OPK stock can currently be purchased for approximately $4.02.

How much money does OPKO Health make?

OPKO Health has a market capitalization of $2.74 billion and generates $1.44 billion in revenue each year. The biotechnology company earns $30.59 million in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does OPKO Health have?

OPKO Health employs 5,269 workers across the globe.

What is OPKO Health's official website?

The official website for OPKO Health is www.opko.com.

Where are OPKO Health's headquarters?

OPKO Health is headquartered at 4400 BISCAYNE BLVD., MIAMI FL, 33137.

How can I contact OPKO Health?

OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at (305) 575-4100, via email at [email protected], or via fax at 305-575-6015.


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.